Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Evolus (EOLS) Operating Expenses: 2018-2025

Historic Operating Expenses for Evolus (EOLS) over the last 8 years, with Sep 2025 value amounting to $57.3 million.

  • Evolus' Operating Expenses fell 0.40% to $57.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $229.6 million, marking a year-over-year increase of 37.61%. This contributed to the annual value of $216.7 million for FY2024, which is 16.01% up from last year.
  • Per Evolus' latest filing, its Operating Expenses stood at $57.3 million for Q3 2025, which was up 3.26% from $55.5 million recorded in Q2 2025.
  • Evolus' Operating Expenses' 5-year high stood at $64.5 million during Q2 2023, with a 5-year trough of -$4.6 million in Q4 2022.
  • Over the past 3 years, Evolus' median Operating Expenses value was $55.5 million (recorded in 2025), while the average stood at $52.6 million.
  • Data for Evolus' Operating Expenses shows a peak YoY increase of 1,070.96% (in 2022) and a maximum YoY decrease of 108.65% (in 2022) over the last 5 years.
  • Quarterly analysis of 5 years shows Evolus' Operating Expenses stood at $52.7 million in 2021, then plummeted by 108.65% to -$4.6 million in 2022, then spiked by 212.31% to $5.1 million in 2023, then spiked by 973.20% to $54.9 million in 2024, then decreased by 0.40% to $57.3 million in 2025.
  • Its last three reported values are $57.3 million in Q3 2025, $55.5 million for Q2 2025, and $61.8 million during Q1 2025.